BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35373903)

  • 41. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
    Seco J; Gu G; Marcelos T; Kooy H; Willers H
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?
    Ntentas G; Dedeckova K; Andrlik M; Aznar MC; George B; Kubeš J; Darby SC; Cutter DJ
    Pract Radiat Oncol; 2019 May; 9(3):179-187. PubMed ID: 30708133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer.
    Roelofs E; Engelsman M; Rasch C; Persoon L; Qamhiyeh S; de Ruysscher D; Verhaegen F; Pijls-Johannesma M; Lambin P;
    J Thorac Oncol; 2012 Jan; 7(1):165-76. PubMed ID: 22071782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Out-of-field doses in pediatric craniospinal irradiations with 3D-CRT, VMAT, and scanning proton radiotherapy: A phantom study.
    Majer M; Ambrožová I; Davídková M; De Saint-Hubert M; Kasabašić M; Knežević Ž; Kopeć R; Krzempek D; Krzempek K; Miljanić S; Mojżeszek N; Veršić I; Stolarczyk L; Harrison RM; Olko P
    Med Phys; 2022 Apr; 49(4):2672-2683. PubMed ID: 35090187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fraction optimization for hybrid proton-photon treatment planning.
    Li W; Zhang W; Lin Y; Chen RC; Gao H
    Med Phys; 2023 Jun; 50(6):3311-3323. PubMed ID: 36786202
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dosimetric comparison between VMAT with different dose calculation algorithms and protons for soft-tissue sarcoma radiotherapy.
    Fogliata A; Scorsetti M; Navarria P; Catalano M; Clivio A; Cozzi L; Lobefalo F; Nicolini G; Palumbo V; Pellegrini C; Reggiori G; Roggio A; Vanetti E; Alongi F; Pentimalli S; Mancosu P
    Acta Oncol; 2013 Apr; 52(3):545-52. PubMed ID: 22671576
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Training and validation of a knowledge-based dose-volume histogram predictive model in the optimisation of intensity-modulated proton and volumetric modulated arc photon plans for pleural mesothelioma patients.
    Franceschini D; Cozzi L; Fogliata A; Marini B; Di Cristina L; Dominici L; Spoto R; Franzese C; Navarria P; Comito T; Reggiori G; Tomatis S; Scorsetti M
    Radiat Oncol; 2022 Aug; 17(1):150. PubMed ID: 36028862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma : A dosimetric comparison.
    Adeberg S; Harrabi SB; Bougatf N; Bernhardt D; Rieber J; Koerber SA; Syed M; Sprave T; Mohr A; Abdollahi A; Haberer T; Combs SE; Herfarth K; Debus J; Rieken S
    Strahlenther Onkol; 2016 Nov; 192(11):770-779. PubMed ID: 27334276
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proton radiation therapy (PRT) for pediatric optic pathway gliomas: comparison with 3D planned conventional photons and a standard photon technique.
    Fuss M; Hug EB; Schaefer RA; Nevinny-Stickel M; Miller DW; Slater JM; Slater JD
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1117-26. PubMed ID: 10613303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours.
    Cozzi L; Fogliata A; Lomax A; Bolsi A
    Radiother Oncol; 2001 Dec; 61(3):287-97. PubMed ID: 11730999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Short-course PET based simultaneous integrated boost for locally advanced cervical cancer.
    Arnesen MR; Rekstad BL; Stokke C; Bruheim K; Løndalen AM; Hellebust TP; Malinen E
    Radiat Oncol; 2016 Mar; 11():39. PubMed ID: 26968827
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dosimetric impact of reduced nozzle-to-isocenter distance in intensity-modulated proton therapy of intracranial tumors in combined proton-carbon fixed-nozzle treatment facilities.
    Jelen U; Bubula ME; Ammazzalorso F; Engenhart-Cabillic R; Weber U; Wittig A
    Radiat Oncol; 2013 Sep; 8():218. PubMed ID: 24047482
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In silico comparison of whole pelvis intensity-modulated photon versus proton therapy for the postoperative management of prostate cancer.
    Gogineni E; Cruickshank IK; Chen H; Halthore A; Li H; Deville C
    Acta Oncol; 2023 Jun; 62(6):642-647. PubMed ID: 37345868
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A treatment planning inter-comparison of proton and intensity modulated photon radiotherapy.
    Lomax AJ; Bortfeld T; Goitein G; Debus J; Dykstra C; Tercier PA; Coucke PA; Mirimanoff RO
    Radiother Oncol; 1999 Jun; 51(3):257-71. PubMed ID: 10435821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis.
    Holliday EB; Kocak-Uzel E; Feng L; Thaker NG; Blanchard P; Rosenthal DI; Gunn GB; Garden AS; Frank SJ
    Med Dosim; 2016; 41(3):189-94. PubMed ID: 27158021
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dosimetric impact of random spot positioning errors in intensity modulated proton therapy plans of small and large volume tumors.
    Arjunan M; Krishnan G; Sharma DS; M P N; Patro KC; Thiyagarajan R; Srinivas C; Jalali R
    Br J Radiol; 2021 Mar; 94(1119):20201031. PubMed ID: 33529057
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Potential Role of Intensity-Modulated Proton Therapy in Hepatic Carcinoma in Mitigating the Risk of Dose De-Escalation.
    Cozzi L; Comito T; Loi M; Fogliata A; Franzese C; Franceschini D; Clerici E; Reggiori G; Tomatis S; Scorsetti M
    Technol Cancer Res Treat; 2020; 19():1533033820980412. PubMed ID: 33287650
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hybrid proton-photon inverse optimization with uniformity-regularized proton and photon target dose.
    Gao H
    Phys Med Biol; 2019 May; 64(10):105003. PubMed ID: 30978714
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Temporal lobe sparing radiotherapy with photons or protons for cognitive function preservation in paediatric craniopharyngioma.
    Toussaint L; Indelicato DJ; Muren LP; Li Z; Lassen-Ramshad Y; Kirby K; Pedro C; Mikkelsen R; Di Pinto M; Høyer M; Stokkevåg CH
    Radiother Oncol; 2020 Jan; 142():140-146. PubMed ID: 31472997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.